Last Updated on December 21, 2024 by The Health Master
USFDA approval
Johnson & Johnson (J&J) has received a significant U.S. Food and Drug Administration approval (USFDA approval).
The USFDA has approved the company’s innovative medical device, Varipulse, for treating a specific type of heart rhythm disorder.
Understanding the Disorder
The medical device is designed to address drug-refractory paroxysmal atrial fibrillation (PAF).
This condition is characterized by irregular heartbeats that occur intermittently, typically lasting from a few minutes to several hours.
Patients suffering from this condition often find traditional drug treatments ineffective.
How Varipulse Works
Varipulse employs a cutting-edge technology known as pulsed field ablation.
This technique involves delivering precise energy pulses to specific areas within the heart.
These pulses create tiny scars that disrupt the abnormal electrical signals causing the irregular heartbeats.
A Competitive Market
J&J joins a group of leading medical device companies, including Boston Scientific and Medtronic, that offer medical devices to treat atrial fibrillation (AFib).
AFib is a broader category of heart rhythm disorders that includes PAF.
While these companies have established medical devices for AFib, J&J’s Varipulse specifically targets the drug-resistant subset of PAF patients.
The Future of Heart Rhythm Treatments
The USFDA approval of Varipulse signifies a significant step forward in the treatment of heart rhythm disorders.
This innovative medical device offers hope to patients who have not responded to traditional medications.
As medical technology continues to advance, we can expect to see even more effective and minimally invasive treatments for a variety of cardiac conditions.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
Disclaimer: This content, provides generic information only. It is in no way a substitute for a qualified medical opinion. Always consult a specialist or your own doctor for more information. The Health Master does not claim responsibility for this information.
USFDA approval granted for Diltiazem Hydrochloride extended-release capsules
USFDA approval granted for Fludrocortisone Acetate Tablets
USFDA approval granted for generic Cetirizine tablets
USFDA approval granted for Lamotrigine Extended-Release Tablets USP
USFDA approval granted for Cephalexin tablets
USFDA approval granted for Paliperidone extended-release Tablets
Drug recall: Ascorbic Acid Injection recalled due to this reason
Recommendations for New Rules for Nutraceuticals: FSSAI
India needs to boost Vaccine Manufacturing and Research
Anti dumping investigation on Aniline imports from China
USFDA concludes inspection at Granules India with zero observations
Delhi High Court grants Injunction in ‘KIND’ Trademark battle
CDSCO Recruitment Rules for Medical Device Officers: A Closer Look
NPPA Price Fixation upheld for this Multivitamin Tablets
CDSCO Panel nod for Clinical Trial of Ranibizumab Solution for Injection
India Boosts Medical Device Sector with New Rs 500 Crore Scheme
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
